Stocks and Investing
Stocks and Investing
Thu, June 23, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Initiated (TYRA) at Strong Buy and Held Target at $12 on, Jun 23rd, 2022
Raghuram Selvaraju of HC Wainwright & Co., Initiated "Tyra Biosciences, Inc." (TYRA) at Strong Buy and Held Target at $12 on, Jun 23rd, 2022.
Raghuram has made no other calls on TYRA in the last 4 months.
There is 1 other peer that has a rating on TYRA. Out of the 1 peers that are also analyzing TYRA, 0 agree with Raghuram's Rating of Hold.
This is the rating of the analyst that currently disagrees with Raghuram
- Maury Raycroft of "Jefferies" Upgraded from Hold to Strong Buy and Decreased Target to $27 on, Tuesday, March 8th, 2022
Contributing Sources